TARPLIN, DOWNS & YOUNG, LLC

Lobbying for NOVO NORDISK INC. · A global healthcare company focused on diabetes and other serious chronic diseases

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $60,000.00 income · posted Jul 20, 2026

Lobbying activity 3

Health Issues

Lobbying related to pharmaceutical policy and access

Medicare/Medicaid

Lobbying related to pharmaceutical policy and access

Budget/Appropriations

Federal budget issues

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.